Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microbiota Transplant Therapy in Alopecia Areata
NCT06747611Phase 2Recruiting
- Sponsor
- University of Minnesota
- Start
- Aug 2025
- Primary completion
- Mar 2028
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alopecia areata (2 arms), sponsored by University of Minnesota. Primary endpoint: Microbiome Engraftment at 8 weeks. Started Aug 2025; status: recruiting.
02
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT06747611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06747611.